Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Linxiang,Zhang ^[1] ; Xueying,Zhang ^[2] ; Yan,Shi ^[1] ; Yuhan,Ni ^[2] ; Jiaojiao,Fei ^[1] ; Zhixin,Jin ^[2] ; Wenjuan,Li ^[1] ; Xiaojing,Wang ^[2] ; Nan,Wu ^[1]

作者单位： Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, The Department of Pulmonary Critical Care Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China. ^[1] Joint Research Center for Regional Diseases of Institute of Health and Medicine (IHM), The First Affiliated Hospital of Bengbu Medical College, Bengbu, China. ^[2]

关键词 cancer therapy drug resistance epigenetics histone methyltransferases lung cancer

DOI 10.3389/fonc.2024.1376916

PMID 38525426

发布时间 2024-03-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2024年14卷

1376916页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除